Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.

European journal of neurology - 1 Oct 2007

Kalinderi K, Fidani L, Bostantjopoulou S, Katsarou Z, Kotsis A

Abstract excerpt

Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting approximately 2% of the population >60 years of age. Although, the etiology of PD is still unknown, the genetic background of the disease has been documented. Recently, a mutation in the LRRK2 gene, G2019S, was associated with 3-41% and 1-2% of familial and sporadic PD, respectively suggesting a pivotal role of LRRK2 in PD. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to Cohort Studies
Share to Glycine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Greece

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Parkinson Disease

Share to Protein Serine-Threonine Kinases

Share to Serine

Source

Identifiers

PMID: 17880562
DOI: 10.1111/j.1468-1331.2007.01867.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.PMID 17880562Read ↗

Is the G2019S LRRK2 mutation common in all southern European populations?Semantic proximity Read ↗

G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease.Semantic proximity Read ↗

Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.Semantic proximity Read ↗

LRRK2 mutations are a common cause of Parkinson's disease in Spain.Semantic proximity Read ↗

G2019S LRRK2 mutation in French and North African families with Parkinson's disease.Semantic proximity Read ↗

Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.Semantic proximity Read ↗

Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.Semantic proximity Read ↗

G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort.Semantic proximity Read ↗

Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.Semantic proximity Read ↗

LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease.Semantic proximity Read ↗

The p.Gly2019Ser is the commonest pathogenic mutation in the LRRK2 gene among Egyptians with familial and sporadic Parkinson's diseaseSemantic proximity Read ↗

A study of LRRK2 mutations and Parkinson's disease in Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.